Kern Pharma Worldwide

Kern Pharma is committed to improve patient lives all around the world, distributing its medicinal products in more than 60 countries and having two International subsidiaries in Portugal and USA:

Kern Pharma strengthen its development and internationalization in Europe, Asia, Latin America, MENA and CIS regions with its products being developed and manufactured in its own facilities and throughout the following business models:

  • Qualified, strategic and solid long-term partnership alliances
  • License and supply agreements with other pharmaceuticals companies

Kern Pharma also commercialise Active Pharmaceutical Ingredients (APIs) with high added value:

  • Conventional ones used in human and animal care
  • Fentanyl family used in the manufacturing of narcotic drugs